Currus Biologics

Melbourne, Australia · Founded 2020 · Privately Held (backing)

Developer of CAR-T cell therapies designed to treat solid cancers. Currus Biologics is based in Melbourne, Australia and was founded in 2020. Its last reported valuation was $21.6 million in Oct 2025. It has raised $19.3 million.

Last reported valuation

$21.6M

Oct 2026

Priced at

—

Total raised

$19.3M

Last round

—

How much has Currus Biologics raised?

$19.3Macross 0 recorded rounds

Free account

More of Currus Biologics with a free account

·Watch Currus Biologics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Currus Biologics investors

6 investors are on record for Currus Biologics, including Main Sequence Ventures, Brandon Capital, ANDHealth and Brandon Biocatalyst.

For fundraisers

Raising for a company like Currus Biologics?

6 investors have backed Currus Biologics.

See all 6 investors →

Frequently asked about Currus Biologics

How much has Currus Biologics raised?: Currus Biologics has raised $19.3M in total across 0 recorded funding rounds.